These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6809469)

  • 1. Serum thyroglobulin and its autoantibody following subtotal thyroid resection of Graves' disease.
    Feldt-Rasmussen U; Blichert-Toft M; Christiansen C; Date J
    Eur J Clin Invest; 1982 Jun; 12(3):203-8. PubMed ID: 6809469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with Graves' disease during antithyroid drug therapy.
    Aizawa T; Ishihara M; Koizumi Y; Hashizume K; Takasu N; Yamada T; Kobayashi I; Watanabe T; Shimizu Z
    Am J Med; 1990 Aug; 89(2):175-80. PubMed ID: 2166430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of higher levels of thyroglobulin, but not thyroid autoantibodies, in the thyroid vein in Graves' disease.
    Chou FF; Wang PW; Sheen-Chen SM
    J Endocrinol Invest; 1994 Jan; 17(1):41-4. PubMed ID: 7911812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in thyroid volume during antithyroid drug therapy for Graves' disease and its relationship to TSH receptor antibodies, TSH and thyroglobulin.
    Yamaguchi Y; Inukai T; Iwashita A; Nishino M; Yamaguchi T; Shohda Y; Shimomura Y; Ohshima K; Kobayashi S; Kobayashi I
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):411-5. PubMed ID: 1978459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thyroglobulin, its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmos.
    Feldt-Rasmussen U; Kemp A; Bech K; Madsen SN; Date J
    Acta Endocrinol (Copenh); 1981 Feb; 96(2):192-8. PubMed ID: 6894054
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves' disease.
    Shimizu K; Kumita S; Kitamura Y; Nagahama M; Kitagawa W; Akasu H; Oshina T; Kumasaki T; Tanaka S
    J Am Coll Surg; 2002 Jan; 194(1):14-22. PubMed ID: 11800336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of calcium and parathyroid hormone after subtotal thyroid resection for Graves' disease.
    Aagaard J; Blichert-Toft M; Christiansen C
    Acta Med Scand; 1982; 211(4):261-4. PubMed ID: 6896600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyroglobulin: an early indicator of autoimmune post-partum thyroiditis.
    Parkes AB; Black EG; Adams H; John R; Richards CJ; Hall R; Lazarus JH
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):9-14. PubMed ID: 8050135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism.
    Martino E; Balzano S; Bartalena L; Loviselli A; Sica V; Petrini L; Grasso L; Piga M; Braverman LE
    J Endocrinol Invest; 1991 Nov; 14(10):847-51. PubMed ID: 1687043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
    Izumi M; Larsen PR
    Metabolism; 1978 Apr; 27(4):449-60. PubMed ID: 580305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with thyroglobulin induces Graves'-like disease in mice.
    Endo T; Kobayashi T
    J Endocrinol; 2009 Aug; 202(2):217-22. PubMed ID: 19491147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triiodothyronine autoantibodies in Graves' disease: their changes after antithyroid therapy and relationship with the thyroglobulin antibodies.
    Wang PW; Huang MJ; Liu RT; Chen CD
    Acta Endocrinol (Copenh); 1990 Jan; 122(1):22-8. PubMed ID: 1689529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.
    Werner RS; Romaldini JH; Farah CS; Werner MC; Bromberg N
    Thyroid; 1991; 1(4):293-9. PubMed ID: 1688155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.